Daniel Martin speaks with Professor Edmund Lau, lung specialist from Royal Prince Alfred Hospital and Professor of Medicine ...

specifically pulmonary hypertension secondary to left heart failure with preserved ejection fraction (“PH-HFpEF”). In patients with PH-HFpEF, chronic heart failure leads to increased blood pressure in ...

The researchers described the extreme “pre-morbid” vulnerability of older hostages along with the additional data on their ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

"As the mother of a daughter who was diagnosed with severe Pulmonary Arterial Hypertension (PAH) in 2014 at the age of 24 and the Board Chair at PHA Canada, I am very aware of the burdens that this ...

Severe dyspnea is a significant predictor of poor sleep ... may enhance symptomatic treatment and management of PAH. Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep ...

SOVAH Health in Danville was recently recognized as "high performing" by the U.S. News and World Report, the health group ...

Patient enrollment in the Phase 1b hemodynamic trial remains ahead of expectation, with topline results now expected in late Q1’2025 or early ...

Since the program’s inception, the Temple Healthy Chest Initiative has offered low-dose computed tomography (LDCT) scans to detect lung cancer and other conditions at an earlier stage. As of October ...

The following is a summary of “Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial,” ...

Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...

A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the ...